Navigation Links
PCMA Statement on Baucus-Conrad Comparative Effectiveness Legislation
Date:8/1/2008

WASHINGTON, August 1 /PRNewswire-USNewswire/ -- Mark Merritt, President of the Pharmaceutical Care Management Association, issued the following statement in response to new comparative effectiveness legislation introduced late this week by Senate Finance Committee Chair Max Baucus (D-Mont.) and Senate Budget Committee Chair Kent Conrad (D-N.D.):

"We applaud Senators Baucus and Conrad for helping advance the discussion about how best to improve quality through more objective information and to foster value-based purchasing. We look forward to reviewing the Baucus-Conrad legislation in greater detail and working collaboratively with them and other stakeholders in this area.

"PBMs have been at the forefront of efforts to bring more measurement, accountability, and real-time information to the health care system. PCMA believes comparing the clinical effectiveness of competing drug therapies is an important tool in promoting value-based purchasing. Pharmacy benefit managers have led the way with pharmacy & therapeutics (P&T) committees and a wide range of proven utilization tools--including multi-tier formularies and step therapy--to ensure patients have access to cost-effective and clinically proven prescription drugs."

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... to use a laser to measure people,s blood sugar, ... to a portable size, the technique could allow diabetics ... blood. , "We are working hard to turn engineering ... their daily lives," said Claire Gmachl, the Eugene Higgins ... "With this work we hope to improve the lives ...
(Date:8/21/2014)... a genetically engineered line of mice that is expected ... Alzheimer,s and other diseases. , The mice carry ... in response to different calcium levels. This will allow ... to be studied in a new way. , "This ... brain works," said Petr Tvrdik, Ph.D., a research ...
(Date:8/21/2014)... 21, 2014 Entries are now open ... only comprehensive national awards program totally dedicated to recognizing ... and executive leadership. The entry deadline is Oct. 17. ... Estate Insights™, the first and only national magazine entirely ... investment. , “We launched the HREI Insights Awards program ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black Americans are ... racial groups battling the blood sugar disease, a new ... National Health and Nutrition Examination Survey, which evaluates about ... the highest rates of a condition known as diabetic ... blindness in people with diabetes. Diabetic macular edema ...
(Date:8/21/2014)... According to the new report “Waterborne Coatings ... PTFE, PVDF, PVDC, & Others), by Application (Architectural, ... & Others) - Global Forecast to 2019” published ... estimated to reach $77,838.71 Million by 2019. , ... spread through 225 Slides and in-depth TOC on ...
Breaking Medicine News(10 mins):Health News:Laser device may end pin pricks, improve quality of life for diabetics 2Health News:Laser device may end pin pricks, improve quality of life for diabetics 3Health News:Mouse model for epilepsy, Alzheimer's gives window into the working brain 2Health News:Entries Open for 2014 HREI Insights Awards™ 2Health News:Entries Open for 2014 HREI Insights Awards™ 3Health News:Entries Open for 2014 HREI Insights Awards™ 4Health News:Blacks May Face Higher Risk of Diabetes-Linked Vision Loss 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 3Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 4
... Ohio State University Medical Center Implants Two Patients ... Clinical TrialSYDNEY, and TUSTIN, Calif., April 21 Sunshine ... on innovative heart assist technologies, announced today that The ... Ohio has successfully completed the first two implants of ...
... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), ... device to treat infectious disease, today announced ... to lead its investor relations outreach programs. ... first medical device that can selectively remove ...
... Extend National Diabetes Awareness Campaign in Six Additional CitiesBRIDGEWATER, ... star Ben Vereen will reprise his role as a ... Diabetes Awareness with sanofi-aventis U.S. to share his ... extend the national campaign he kicked off in September ...
... site to help raise awareness of deadliest form of ... of Skin Cancer Awareness Month and the increasing incidence ... Society for Dermatologic Surgery (ASDS) has created a free ... Facebook site. The kit and site were created to ...
... cord injuries much more common than thought , , TUESDAY, April ... million people, live with some form of paralysis, a new ... now, said Joseph Canose, vice president of quality of life ... survey Tuesday. The foundation was created by the late actor ...
... Money-Saving Options Now Available through Schiff(R) Loyalty RewardsSALT LAKE ... the most trusted and respected brands in the nutritional ... Schiff(R) Loyalty Rewards. The new incentive program offers ... Schiff(R) Glucosamine product purchased (at participating retailers). These ...
Cached Medicine News:Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 2Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 3Health News:First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure 4Health News:Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs 2Health News:Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs 3Health News:Video: American Performing Icon Ben Vereen Encourages People to 'Take the Stage' and Act on Their Diabetes in 2009 2Health News:Video: American Performing Icon Ben Vereen Encourages People to 'Take the Stage' and Act on Their Diabetes in 2009 3Health News:Video: American Performing Icon Ben Vereen Encourages People to 'Take the Stage' and Act on Their Diabetes in 2009 4Health News:The ASDS Introduces the First At-Home Skin Cancer Exam Kit 2Health News:One in 50 Americans Lives With Paralysis 2Health News:One in 50 Americans Lives With Paralysis 3Health News:Schiff(R) Unveils Loyalty Program to Reward Valued Customers 2
(Date:8/21/2014)... R.I. , Aug. 21, 2014 CVS Caremark ... tender results, applicable Reference Yields and consideration payable in connection ... commenced on August 7, 2014 for (1) any and all ... All Notes") and (2) up to a maximum amount of ... 2041 and 5.750% Senior Notes due 2017 (collectively, the "Maximum ...
(Date:8/21/2014)... , Aug. 21, 2014 Professional Compounding ... paediatric medicine by awarding the three best scientific ... initiative (EuPFI) conference . The Formulating Better ... 18 in Athens, Greece , ... students and professionals, from which three winners will ...
(Date:8/21/2014)... 2014   Royal Philips (NYSE: ... has received 510(k) clearance from the U.S. Food ... application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through ... with pre-procedural, high-precision positioning to treat aortic stenosis ... is available as part of Philips IntelliSpace ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3
... Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: ... of the peer reviewed journal, Leukemia & ... of a phase I/II clinical trial evaluating the ... in treating patients with aggressive non-Hodgkin,s lymphoma ("NHL") ...
... BASKING RIDGE, N.J., April 3, 2011 Regado Biosciences, ... antithrombotic aptamers with active control agents, announced today the ... of the company,s lead product, the anticoagulation system REG1, ... Cardiology 2011 60th Annual Scientific Session & Expo in ...
Cached Medicine Technology:Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 2Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 3Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 4Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 5Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy 6Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System 2Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System 3Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System 4Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System 5
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
... TT™ offers the ultimate research level wireless ... knowledgeable clinician and researcher today. Offering superb ... to meet your desired footprint requirements. Choose ... display live data both in the room ...
... diagnostic capabilities combined with ease of use ... in its class. Ideal for office or ... system for Uroflowmetry, cystometry, leak point pressure, ... are available which make the OM-5 flexible ...
... diagnostic capabilities combined with ease of use ... in its class. Ideal for office or ... system for Uroflowmetry, cystometry, leak point pressure, ... are available which make the OM-5 flexible ...
Medicine Products: